Objective: To compare the glaucoma hemifield test (ght) results of the central 30-2 threshold test vs. central 30-2 sita standard test in glaucoma suspect patients without expierence in automated perimetry. Methods: U...Objective: To compare the glaucoma hemifield test (ght) results of the central 30-2 threshold test vs. central 30-2 sita standard test in glaucoma suspect patients without expierence in automated perimetry. Methods: Using the humphrey visual field analyzer model 745, 100 subjects were tested with central 30-2 threshold test (group a) and 100 subjects were tested with cen-展开更多
Purpose: To evaluate the clinical outcome of transscleral cy-clophotocoagulation (TSCPC) with diode laser in high risk glaucomas as a primary treatment Methods: A prospectively study was done of 15 patients (17 eyes) ...Purpose: To evaluate the clinical outcome of transscleral cy-clophotocoagulation (TSCPC) with diode laser in high risk glaucomas as a primary treatment Methods: A prospectively study was done of 15 patients (17 eyes) with different glaucomas. Average age 55years. Follow-up ranged from 6 to 36 months. Most of the patients had neovascular glaucoma (13eyes), chronic展开更多
文摘Objective: To compare the glaucoma hemifield test (ght) results of the central 30-2 threshold test vs. central 30-2 sita standard test in glaucoma suspect patients without expierence in automated perimetry. Methods: Using the humphrey visual field analyzer model 745, 100 subjects were tested with central 30-2 threshold test (group a) and 100 subjects were tested with cen-
文摘Purpose: To evaluate the clinical outcome of transscleral cy-clophotocoagulation (TSCPC) with diode laser in high risk glaucomas as a primary treatment Methods: A prospectively study was done of 15 patients (17 eyes) with different glaucomas. Average age 55years. Follow-up ranged from 6 to 36 months. Most of the patients had neovascular glaucoma (13eyes), chronic
